T-ALL

Clinical trials for T-ALL explained in plain language.

Never miss a new study

Get alerted when new T-ALL trials appear

Sign up with your email to follow new studies for T-ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

Promising leukemia combo trial pulled before it even started

Disease control Terminated

This trial aimed to test a new drug called CM313, a CD38-targeting antibody, combined with a chemotherapy regimen inspired by pediatric treatments for adults newly diagnosed with T-cell acute lymphoblastic leukemia (T-ALL). The goal was to see if the combination could improve rem…

Matched conditions: T-ALL

Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Jun 22, 2026 11:57 UTC

T-ALL

Get alerted when new T-ALL trials appear

Promising leukemia combo trial pulled before it even started